1Targeted-regulation of TIMP2 expression by microRNA-483-5p and its effect on the proliferation and invasion of bladder cancer cellsZHANG Tiantian, ZHOU Zhenghai, GUO Yuanyuan, WANG RuiARTICLES209-2142Role of ATM/CXCL12 in macrophage M2 polarization induced by castrated tolerant prostate cancer cellsXUAN Rui, ZHU Jin, ZHOU Yibin, ZANG Yachen, XUE Boxin, XU LijunARTICLES215-2203Targeting regulation of Smad4 by microRNA-190b-5p and its effect on TGF-β1-induced migration,invasion and epithelial-mesenchymal transition of rectal cancer cellsWANG Yuhao, ZHANG YouyuanARTICLES221-2264Effects of GLTSCR2 on migration,invasion and p53 signaling pathway of ovarian cancer cellsGAN Hongmei, LUO Ying, ZHANG YanqingARTICLES227-2325Effects of LEF1-AS1 on migration and invasion of gastric cancer cells through Wnt/β-catenin signaling pathwayHENG Dongmei, FU Wenlan, TANG XueqinARTICLES233-2386Effects of LINC00092 on migration and invasion of osteosarcoma cells by targeting microRNA-373-5pZHOU Hao, XU Zechuan, XU Chi, WANG Xiang, KUANG Song, HUANG YuARTICLES239-2447Expression and clinical significance of CXCL10 and CXCL16 in gliomas based on bioinformatics analysisWANG Xindi, HUANG Zhuoyan, JIANG Xudong, ZHANG LinaARTICLES245-2508Prognostic value of tissue RP11-388M20.1 level in patients with gastric cancer undergoing radical gastrectomyMIAO Lili, SUN Jiaxing, SHANG Ying, CAI Jundong, CAI JingqingARTICLES251-2549Relationship of GIPR expression with clinicopathological features and immune infiltration in gastric cancer tissuesSHEN Huaishu, DONG XueARTICLES255-25810Expression of BARD1 in esophageal squamous carcinoma tissues and its correlation with lymph node metastasisPAN Yi, PANG Yaqing, WU XianzhongARTICLES259-26211Expression and clinical significance of IPO5P1 in prostate cancer tissuesXIA Zhizhong, SUN Bin, LI Yinnan, SHEN Wei, ZHANG Yunwei, WANG ShaochengARTICLES263-26612Level and clinical significance of circular RNA circSMAD2 in glioma tissuesDING Yuzhao, FU Jingbo, ZHENG Xisheng, LI Changli, ZHANG YuanfengARTICLES267-27113Expression and clinical significance of GLRX in cervical cancer tissuesMENG Xiaozheng, CHEN Lu, DU Xiaojuan, QIAO Liang, ZHANG ZhengmingARTICLES272-27514Efficacy and safety observation on PD-1 inhibitors in the cross-line treatment of advanced gastric cancerLU Xiao, GU Yulan, KONG Jiong, WANG Jian, CHEN Qinghua, HE Yun, FU WeiCLINICAL PRACTICE276-27915White paper on standardized continuous use of immunotherapy for non-small cell lung cancerChinese Society of Clinical Oncology Expert Committee on Immunotherapy, WANG BaochengGUIDELINE AND INTERPRETATION280-28716Current status of research on quadruple-negative breast cancerLU Yueyao, DENG Jianzhong, LIU Qian, LU WenbinREVIEWS AND LECTURES288-29317Progress in diagnosis and treatment of immune checkpoint inhibitor-associated pneumoniaXIA Tingting, YANG Zhenhua, ZHANG KaiREVIEWS AND LECTURES294-29918Research progress of maintenance drugs for platinum-sensitive recurrent ovarian cancerHU Xiaojing, ZHANG Rongchang, JIN ShuanglingREVIEWS AND LECTURES300-30419Research progress of STING agonists and tumorSHEN Xiulan, ZHAO Lizhi, DENG Rong, XU WenREVIEWS AND LECTURES305-309 